经静脉导管消融治疗顽固性快速性心律失常是近十年来心血管病学的进展之一。晚近,许多学者在能量形式及临床应用等方面作了进一步的探索,又取得了一些新进展。本文特作如下综述。一、不断探索新的能量形式 1981年,Scheinman等首次报道1例经多种抗心律失常药物治疗不能控制的顽固性室上性心动过速(RSVT)患者,通过采用经静脉导管传送直流电(监护除颤器供能,R波同步放电)进行心内电击阻断希氏束,造成完全性房室传导阻滞,然后置入永久性人工心脏起搏器而成功地治疗了RSVT。随后,Weber等、Hartzier等将此技术相继用于阻断房室旁道 Intravenous catheter ablation of refractory tachyarrhythmia is one of the advances in cardiovascular disease in the past decade. Recently, many scholars have made further exploration in terms of energy forms and clinical applications, and made some new progress. This article special for the following overview. First, continue to explore new forms of energy In 1981, Scheinman, etc. for the first time reported a case of refractory patients with refractory supraventricular tachycardia (RSVT) can not be controlled by a variety of anti-arrhythmic drugs, through the use of intravenous catheter delivery of DC Defibrillator-powered, R-wave synchronized discharges) to block the His bundle, resulting in complete atrioventricular block and then successfully treating RSVT with a permanent artificial pacemaker. Subsequently, Weber et al., Hartzier et al. Used this technique in succession to block atrioventricular bypass